Next Article in Journal
Model of an Artificial Neural Network for Solving the Problem of Controlling a Genetic Algorithm Using the Mathematical Apparatus of the Theory of Petri Nets
Next Article in Special Issue
Antimicrobial Properties, Cytotoxic Effects, and Fatty Acids Composition of Vegetable Oils from Purslane, Linseed, Luffa, and Pumpkin Seeds
Previous Article in Journal
Methods for Improving Image Quality for Contour and Textures Analysis Using New Wavelet Methods
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity

by
Małgorzata Ziarno
1,*,
Mariola Kozłowska
2,
Iwona Ścibisz
3,
Mariusz Kowalczyk
4,
Sylwia Pawelec
4,
Anna Stochmal
4 and
Bartłomiej Szleszyński
5
1
Division of Milk Technology, Department of Food Technology and Assessment, Institute of Food Science, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland
2
Department of Chemistry, Institute of Food Science, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland
3
Division of Fruit, Vegetable and Cereal Technology, Department of Food Technology and Assessment, Institute of Food Science, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland
4
Department of Biochemistry and Crop Quality, Institute of Soil Science and Plant Cultivation, State Research Institute, 24-100 Puławy, Poland
5
Institute of Horticultural Sciences, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Appl. Sci. 2021, 11(9), 3898; https://doi.org/10.3390/app11093898
Submission received: 1 April 2021 / Revised: 18 April 2021 / Accepted: 21 April 2021 / Published: 25 April 2021

Abstract

:
This study aimed to investigate the effect of plant extracts (valerian Valeriana officinalis L., sage Salvia officinalis L., chamomile Matricaria chamomilla L., cistus Cistus L., linden blossom Tilia L., ribwort plantain Plantago lanceolata L., marshmallow Althaea L.) on the activity and growth of lactic acid bacteria (LAB) during the fermentation and passage of milk through a digestive system model. The tested extracts were also characterized in terms of their content of polyphenolic compounds and antioxidant activity. It was observed that the addition of the tested herbal extracts did not inhibit the growth of LAB in fermented milk drinks, such as yogurts. However, they can gradually inhibit fermentation when added at concentrations above 2% by weight, and hence should be used in limited amounts. The microflora of yogurts containing the tested herbal extracts did not die during digestion in model digestive juices, and no stimulating effect of the added plant extracts was noted either. Nevertheless, due to the antioxidant properties, a slight addition of the herbal extracts containing polyphenols to different kinds of food products can increase the nutritional quality, thus making them functional foods.

1. Introduction

The benefits of fermented milk drinks seem to be recognized by consumers as the consumption of these products continues to increase, particularly in industrialized countries. In recent years, manufacturers have been outdoing each other in inventing novel products to attract customers. For instance, yogurts are prepared with various fruits, which are often quite exotic and rarely found in local markets. It has been found that plant extracts that were used in folk medicine and sometimes even in culinary applications may serve as interesting additives. However, the effect of their addition on the microflora of fermented milk beverages should be investigated.
Valerian (Valeriana officinalis L.) has been a known herb since ancient Greek and Roman times. The action of this herb was described by Dioscorides, Hippocrates, and Plinius Secundus. Valerian is one of the most popular herbs used in various medications, mainly for its calming and relaxing effects. In folk medicine, it was used as a sedative and as a relaxant of the smooth muscles of the digestive tract, urinary tract, and blood vessels. The name of the herb is derived from the Latin word “valere”, which means “to be healthy” [1,2]. Sage (Salvia officinalis L.) contains compounds that inhibit lipid peroxidation, and also exhibit antibacterial, antiallergic, antiviral, and analgesic properties. In addition, sage is used in medicine to fight rheumatism and arthritis, and sometimes to prevent the general weakening of the body [3,4,5]. Chamomile (Matricaria chamomilla L.) has been used for centuries as a poultice for healing wounds and burns, and as an eyewash to treat conjunctivitis. This herb has not lost its relevance [6,7,8]. It is known to have anti-inflammatory, antibacterial, bacterial toxin-binding, disinfectant, antispasmodic, choleretic, sedative, and laxative effects, and is hence used widely in medicine. Furthermore, it is used in the food industry for the production of liqueurs and in the cosmetic industry for the production of creams, lotions, soaps, bath liquids, and toothpastes [6,7,8]. Cistus (Cistus L.) acts as an antioxidant and removes free radicals and prevents the formation of new ones [9,10]; it also has antibacterial, anti-inflammatory, antiviral, and antifungal effects [9,10]. Linden blossom (Tilia L.) exhibits a high healing effect and was therefore used by our ancestors for generations. In traditional medicine, the linden flower is commonly used for nervous tension and excessive nervous excitability. In some cases, it is used as a prophylactic against atherosclerosis and hypertension [11,12,13,14,15,16]. Linden flowers are also characterized by anti-inflammatory, antipyretic, diaphoretic, diuretic, mildly astringent, and analgesic properties [11,12,13,14,15,16]. Since ancient times, infusions prepared from linden or sage have been used to treat respiratory diseases. Ribwort plantain (Plantago lanceolata L.) has also been used in folk medicine. Its leaves are used to treat cuts, bruises, bites, and burns, as well as for chronic gastrointestinal catarrh, acidity, and damage to the gastric and intestinal mucosa (e.g., by bacterial toxins or other chemical compounds) [17,18,19,20]. This herb has bacteriostatic, antimicrobial, anti-inflammatory, antispasmodic, and expectorant properties. It also improves blood clotting and has astringent and sealing effects on blood vessels [17,18,19,20]. Marshmallow (Althaea L.) was valued for its prohealth properties by Egyptians and Syrians in ancient times. The generic name Althaea comes from the Greek word “althe” which means “to heal”. Both the root and leaves of marshmallow are rich in mucus, which is the basic ingredient of this plant used in medicine [21,22,23,24]. Marshmallow has anti-inflammatory, protective, coating, and antitussive properties [21,22,23,24].
In food production, the use of herbs can stabilize the microflora of products, by preventing the development of harmful microorganisms and supporting the growth of desired bacteria. Only few scientific reports have shown that when selected plant extracts are used in appropriate portions, they can have a beneficial effect on lactic acid bacteria (LAB) [25,26]. Bifidobacteria and some lactobacilli can transform polyphenols into important metabolites that have important functions in the human body is known to be [25,26]. Moreover, observations of market trends suggest that plant extracts are used or can be used as food additives in the production of flavored fermented dairy products (including yoghurts or other fermented milks, sour cream, acid and rennet cheeses), and many products derived from them. Only limited studies have analyzed the influence of phenolic compounds on the growth and viability of other lactic acid bacteria such as Streptococcus thermophilus used in the production of yogurt.
The present study aimed to investigate the effect of selected herbal additives on the activity and growth of lactic acid bacteria (LAB) during fermentation and passage of milk through the digestive system model. Additionally, the tested extracts were characterized in terms of their content of polyphenolic compounds and antioxidant activity.

2. Materials and Methods

2.1. Materials

The following plant extracts were used in the research: valerian (V. officinalis L.), sage (S. officinalis L.), chamomile (M. chamomilla L.), cistus (Cistus L.), linden blossom (Tilia L.), ribwort plantain (P. lanceolata L.), and marshmallow (Althaea L.). They were purchased from GreenVit sp. z.o.o. (Zambrów, Poland). These were water extracts obtained by percolation at elevated temperatures. Then, they were concentrated in a vacuum evaporator, and possibly dried further under vacuum. Marshmallow and plantain extracts were obtained in liquid form, while the rest were in powder form. Maltodextrin was used as the drying carrier.

2.2. Determination of the Effect of Plant Extracts on the Lactic Acid Fermentation of Milk

In the first stage of the work, the ability of LAB to ferment milk was checked in the presence of selected plant extracts. Briefly, the milk samples intended for lactic acid fermentation was prepared from UHT milk (containing 3.2% of fat) in a volume of 100 mL, and the plant extracts were added at amounts of 0.2, 0.6, 1.0, 1.4, 2.0, 3.0, 4.0, and 5.0%. Then, the samples were transferred to a water bath heated to 42 °C, and the starter culture was added (at an amount of 0.04%). The yogurt starter culture YC-X16 (received kindly from Chr. Hansen Poland) was used in the research. This freeze-dried culture is composed of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus. Fermentation of milk samples was carried out at 42 °C. For the next 4 h, the pH of the samples was measured every 30 min until the end of fermentation, using a standard laboratory stationary pH meter with three replications.

2.3. Determination of the Effect of Plant Extracts on the Populations of Lactic Acid Bacteria

The effect of plant extracts on the population of LAB cells was investigated immediately after the fermentation process and digestion of fermented milk in model digestive juices. At this stage, however, based on the results of the first stage, only the following portions of plant extracts were used: 0.2, 0.6, 1.0, and 1.4% extracts added to UHT milk. Fermentation was carried out as in the first stage of the research. After the end of the process, the number of LAB cells in the samples was determined. M17 (MERCK) and MRS agar (De Man Rogosa Sharpe Agar, MERCK) were used in the analysis. The inoculated Petri plates were incubated in an incubator at 37 °C under aerobic (M17 agar) or anaerobic (MRS agar) condition. The cell count was determined after 72 h, and the results are expressed in colony forming units in 1 mL of the sample (CFU/mL).
The next stage of the work consisted of several steps. The first step involved the digestion of the fermented milk samples added with plant extracts under gastric juice conditions, and the second step involved the digestion of the samples under intestinal juice conditions [27]. Gastric juice was prepared as described by Ziarno and Zaręba [27]. Briefly, 4.8 g of NaCl, 1.56 g of NaHCO3, 2.2 g of KCl, and 0.22 g of CaCl2 were dissolved in 1000 mL of distilled water. The pH of the prepared solution was adjusted to 2.40 with 1 M HCl. Then, the solution was sterilized in an autoclave at 121 °C for 15 min. Immediately before the experiment, pepsin (Sigma-Aldrich) was added to the solution at an amount of 285 µL/100 mL gastric juice. The model intestinal juice was also prepared as described by Ziarno and Zaręba [27]. Briefly, 5 g of NaCl, 0.6 g of KCl, 0.25 g of CaCl2, and 8.5 g of beef bile were dissolved respectively in 1 M NaHCO3. The pH of the prepared solution was adjusted to 7.0 with 1 M HCl. The whole mixture was successively sterilized in an autoclave at 121 °C for 15 min. Immediately before the experiment, one Kreon Travix 10,000 capsule (Abbott Laboratories) was added to 200 mL of model intestinal juice. The capsule contains a mixture of digestive enzymes, which at a dose of 150 mg shows the activity of 10,000 IU Ph. Eur lipase, 8000 units Ph. Eur amylase, and 600 Ph. Eur proteases. Digestion was carried out in a static system by mixing 35 mL of model gastric juice with the appropriate amount of pepsin and 35 mL of fermented milk sample. Gastric juice digestion was performed for 3 h at 37 °C, and then the mixture was transferred to the same amount of model intestinal juice for digestion which lasted for 5 h at 37 °C. Finally, the number of viable LAB cells was determined as described above.

2.4. Determination of TPC of Plant Extracts

Total phenolic content (TPC) was estimated in the plant extracts using the Folin–Ciocalteu method as described previously [28] with a slight modification. First, appropriately diluted plant extract (3 mg/mL) was mixed with deionized water (20 mL) and Folin–Ciocalteu reagent (0.5 mL). After 30 s, 5 mL of Na2CO3 (20%, v/v) was added to the solution. Then, the solution was incubated at 21 °C for 1 h, and its absorbance was measured at 765 nm using a UV/Vis spectrophotometer (Model 8500; Techcomp, Hong Kong). The results were expressed as mg gallic acid equivalents per gram of extract (mg GAE/g extract) using a standard gallic acid calibration curve. The analysis was performed in three independent replications.

2.5. Determination of Antioxidant Capacities of Plant Extracts

Before the analysis of antioxidant activity, each extract (3–6 mg) was diluted with distilled water (2–4 mL). The plant extract solutions were thus prepared in triplicate, and their average values of antioxidant capacity were determined as mmol Trolox equivalents per gram of extract (mmol TE/g extract).
DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging activity was performed according to a procedure described by Yen and Chen [29] with minor modification. Briefly, 1 mL of 0.3 mmol/L freshly prepared DPPH methanol solution was mixed with 0.2 mL of the plant extract solution and 3.8 mL of methanol. The samples were vortex-mixed at high speed for 10 s and incubated for 10 min in the dark at room temperature. Then, their absorbance was measured at 517 nm using a UV/Vis spectrophotometer. A standard curve was obtained using the Trolox standard in the range of 8–40 µmol/L.
ABTS (2,2′-azinobis(3-ethylbenthiazoline-6-sulfonic acid)) radical scavenging activity of the extracts was determined according to the method described by Re et al. [30]. First, the ABTS•+ solution was prepared by mixing ABTS aqueous solution (14 mmol/L) with potassium persulfate aqueous solution (4.9 mmol/L). The prepared solution was kept for 12–16 h in the dark at room temperature. Before the analysis, the ABTS•+ solution was diluted with phosphate-buffered saline (0.01 mol/L, pH 7.4) to achieve an absorbance value of 0.7 ± 0.05 at 734 nm. Then, 40 µL of the plant extract solution or Trolox solution was mixed with 4 mL of ABTS•+ working solution. The reactive mixture was incubated at room temperature in the dark, and after exactly 6 min, its absorbance was recorded at 734 nm. A series of Trolox solutions (final concentrations 0–15 μM) were used for calibration.
FRAP (ferric reducing antioxidant power) assay was performed as described by Benzie and Strain [31] with some modification. Before the assay, the FRAP reagent was freshly prepared by mixing 300 mmol/L acetate buffer (pH 3.6), 20 mmol/L FeCl3 solution, and 10 mmol/L TPTZ (2,4,6-Tris(2-pyridyl)-s-triazine) in 40 mmol/L HCl in a 10:1:1 (v/v/v) proportion and stored away from light. Then, 100 μL of the appropriately diluted sample extract was mixed with 0.3 mL distilled water and 3 mL FRAP reagent. The absorbance of the reaction mixture was measured spectrophotometrically at 593 nm after incubation at 37 °C for 10 min. The blank solution was obtained by mixing 0.3 mL distilled water with 3 mL of FRAP reagent. A standard curve was prepared using Trolox in the range of 80–500 µmol/L. All determinations were carried out in triplicate.

2.6. ESI-QTOF Qualitative Analysis of Plant Extracts

High-resolution liquid chromatography (LC)–mass spectrometry (MS) analyses (exact masses, MS/MS fragmentation patterns, molecular formulas) were performed on a Thermo Scientific Ultimate 3000 RS chromatographic system coupled with a Bruker Impact II HD (Bruker, Billerica, MA, USA) quadrupole time-of-flight (QTOF) mass spectrometer. Chromatographic separations were carried out on a Waters BEH C18 column (2.1×150 mm, 1.7 µm; Milford, MA USA), equipped with precolumn. Mobile phase A used was 0.1% (v/v) formic acid, while mobile phase B was acetonitrile containing 0.1% (v/v) of formic acid. A gradient from 7 to 80% of phase B over 30 min was used for separation. The flow rate was set at 0.5 mL/min, and the column was held at a temperature of 60 °C. The injection volume was 5 µL. The light absorption patterns of the investigated sample components were obtained in the wavelength range of 190–600 nm using a photodiode array detector (Thermo Ultimate DAD-3000) with an analytical flow cell. The column’s effluent was split into 1:3 proportions between the two detectors operating in parallel, the mass spectrometer, and the charged aerosol detector (CAD), to identify the main constituents of the investigated samples. For identification, data were collected from the mass spectral analyses in both positive and negative ion modes with electrospray ionization (ESI). Linear (centroid) mass spectra were acquired over a mass range from m/z 50 to 2000 with the following MS parameters: positive ion capillary voltage, 4.5 kV; negative ion capillary voltage, 3.0 kV, dry gas (N2) flow, 6 L/min; dry gas temperature, 200 °C; and nebulizer gas (N2) pressure, 0.7 bar. Argon was used as the collision gas. The MS/MS collision energy and parent mass isolation width were automatically set between 2.5 and 35 eV and between 2 and 6 mass units, depending on the m/z of the fragmented ion. The parameters for ion transfer were optimized for m/z 50–2000, with collision cell transfer time at 80 µs and prepulse storage at 10 µs. The acquired data were calibrated internally with 10 mM sodium formate introduced to the ion source via a 20-µL loop at the beginning of each separation process. Data processing was carried out using Bruker DataAnalysis 4.3 software. The main components of the sample were identified from the CAD peak areas, while the constituents were identified based on the light absorption properties, precise mass measurements (measurement error <5 ppm) of the primary ion m/z, which allowed for calculating the molecular formula, and software-aided analysis of the isotopic and MS/MS fragmentation patterns [32].

2.7. Statistical Analysis

Multifactor analysis of variance (ANOVA) is used in statistical analysis to determine the influence of significant factors in a multivariate model. This is a typical system used for experimental analysis which, in addition to checking the influence of one factor, allows checking the interaction of individual factors with each other. In this study, in conjunction with ANOVA, Tukey’s test was used at a significance level of 0.05 to analyze the mutual influence of two factors on each other and find those that differ significantly from each other, which shows the pairs that are statistically significant.

3. Results

3.1. Determination of the Effect of Plant Extracts on Lactic Acid Fermentation

In the first stage of the research, changes in the pH of milk samples enriched with portions of plant extracts were analyzed. The obtained results are presented in Figure 1. The change in pH during the fermentation process indicated that none of the added plant extracts inhibited fermentation. Statistical analysis showed that only the milk samples added with the first three doses of the extracts (from 0 to 1.0%) constituted one homogeneous group (p = 0.001), where the pH values were higher by on average 0.2–0.3 than the samples added with higher doses of the tested plant extracts. The milk samples with 1.0% or higher portion of the plant extracts constituted separate homogeneous groups (p = 0.001) for each analyzed extract. It should be noted that the pH did not reduce below 4.5 for the addition of any extract above 2.0% concentration. For selected additives (sage and cistus), a pH of even 4.1 was achieved for the lowest dose, and 4.8 for 5.0% dose. For the remaining additives, the differences in pH observed between their lowest and the highest portion were approximately 0.4. This difference is significant and confirms that a large amount of additives can inhibit the biochemical activity (i.e., acidifying activity) of LAB present in the yogurt starter culture. In all cases of milk samples fermented in the presence of the tested plant extracts, the pH was no longer statistically significantly reduced after 3.5 h of fermentation.

3.2. Determination of the Effect of Plant Extracts on the Populations of Lactic Acid Bacteria

The results of the determination of both tested LAB populations (Table 1) immediately after the end of the fermentation process confirmed that most of the tested plant extracts did not reduce the populations (p < 0.05). This means that the tested LAB cultures well tolerated the presence of the extracts at an amount of up to 3.0% in milk. Only with the addition of sage extract, we observed some slight, but statistically significant, reduction in the Lactobacillus cell population (Table 1).
Further analyses showed that the types of additives and the digestion process had an impact on the population of S. thermophilus cells (p < 0.05); however, no effect on the lactobacilli population was observed (p > 0.05). It should be noted that both bacterial species had different survival rates in the samples and reacted differently to digestion in the model digestive juices (Table 1). Statistical analysis carried out for individual bacterial species showed that only digestion influenced the number of S. thermophilus cells in most cases. The exceptions were the milk samples fermented with the addition of cistus extract and marshmallow extract, in which the digestion step did not statistically significantly influence the S. thermophilus cell population. This may suggest that these two extracts improved the survival of S. thermophilus cells under the conditions of the model digestive system. In the case of Lactobacillus bacteria, neither the type of plant extract or its dose nor digestion in the model digestive system had a statistically significant influence on the bacterial cell population (Table 1).

3.3. TPC and Antioxidant Capacities of Plant Extracts

The phenolic content determined in the tested plant extracts is presented in Table 2. A significant difference was observed in the phenolic content between cistus and linden blossom extracts and the rest of the tested plant extracts. As we mentioned in the materials and methods section marshmallow and plantain extracts were in liquid form while the rest were in powder form. As can be seen from the data presented in Table 2, liquid marshmallow and plantain extracts were not preparations with the lowest total phenolic content, as well as antioxidant capacity. Statistical analysis showed significant differences in the phenolic content, which resulted in the identification of seven homogenous groups (at a 5% significance level).
The plant extracts were also screened for DPPH, ABTS, and FRAP radical scavenging activities. It was observed that cistus and linden blossom extracts exhibited the highest DPPH, ABTS, and FRAP radical scavenging activity, whereas the lowest DPPH, ABTS, and FRAP activity was exhibited by marshmallow, chamomile, and valerian extract, respectively. Correlation analysis between TPC and DPPH radical scavenging ability, TPC and ABTS radical scavenging ability, and TPC and FRAP radical scavenging ability showed a high degree of correlation (r2 = 0.930, 0.923, and 0.931, respectively). However, the r2 values of 0.931, 0.936, and 0.883 determined for correlation between DPPH and ABTS radical scavenging activity, DPPH and FRAP radical scavenging activity, and ABTS and FRAP radical scavenging activity, respectively, indicated that mainly phenolic compounds contributed to the total antioxidant activity in the tested plant extracts.

3.4. Qualitative Analysis of Plant Extracts

The results of ultrahigh-performance LC (UHPLC)-QTOF-CAD analyses of plant extracts are shown in Table 3, Table 4, Table 5, Table 6, Table 7, Table 8 and Table 9. The identified compounds are presented according to their elution order. Compounds were tentatively identified based on their HRMS and HRMS2 spectra. The fragmentation patterns and molecular formulas of the compounds were compared with available literature data.

4. Discussion

4.1. Antimicrobial Activity of Plant Extracts

Our experiments showed that with the increase in dose the tested plant extracts gradually limited the acidifying activity of the tested LAB, but did not limit the viability of these cells. This finding is interesting considering the necessity to keep the LAB cells alive and maintain them biologically active in fermented milk drinks throughout the declared shelf life. Perhaps, these plant extracts could be used in the dose range studied to stop the activity of starter bacteria and consequently prevent acidification of the fermented milk beverages with the cultures used in this study. It should be noted that there are no studies to date in this regard.
Various spices and herbal extract may affect activity or vitality of lactic acid bacteria, and this phenomenon depend on the genus, species and even sometimes strain of lactic bacteria, the species of herbs and the method of obtaining the extract from them. It is known from research that some LABs have the ability to degrade certain phenolic compounds found in food, including those with high antioxidant activity [33]. Polyphenol-resistant bacteria have the ability to metabolize polyphenol compounds, depending on their chemical structure (substitutions in the phenolic ring) and concentration. Lactobacillus plantarum has been described to exhibit several enzymatic activities, such as that of tannase, phenolic acid decarboxylase (PAD), and benzyl alcohol dehydrogenase which can degrade some phenolic compounds [33]. Only limited studies have analyzed the influence of phenolic compounds on the growth and viability of other LAB species [34,35].
We did not observe any negative or positive effect of the added extracts on the viability of lactobacilli cells during the fermentation process. This is in line with the results reported by Otaibi and Demerdash [36], who showed that appropriately selected portions of sage extracts resulted in better survival of yogurt bacterial cells, while El-Nawawy et al. [37] indicated a beneficial effect of extracts on the multiplication of bacteria in yogurt. An increase was observed in the numbers of S. thermophilus cells than L. delbrueckii subsp. bulgaricus. However, after digestion, the number of Streptococcus cells decreased by an average of 1 log cycle, while the population of Lactobacillus cells remained stable. This is also confirmed by the studies of Zaręba et al. [38] and Ziarno and Margol [39], which proves that LAB poorly tolerate digestive juices, but their survival rate is highly dependent on the culture used. The results obtained in this study thus confirm that the viability of LAB in selected starter cultures can be maintained at a fairly high level, even under such drastic conditions as digestive juices.
There are studies on the antimicrobial effect of plant extracts available in the literature. The antimicrobial activity of plant extracts investigated in this work is often the subject of scientific research [40], but only a few concern the effect of extracts on the activity or population of selected LABs [36]. Due to the lack of comprehensive information on the effect of selected plant extracts on LABs, it is worth taking a brief look at the effect of other plant additives on the bacteria in question. Fortunately, a few reports are found in the literature on the beneficial or inhibitory effects of different plant additives on LABs [41,42,43,44,45,46].
Among the few publications dealing with the effects of valerian (V. officinalis L.) on bacteria, there are some reports on its antibacterial activity [47]. However, no data are available regarding the effect of purge on LABs. Sage (S. officinalis L.) oils have proven antibacterial and antifungal properties [40,48,49,50]. Their effect on yogurt bacteria has also been studied proving that the appropriate portions of these additives do not inhibit the growth of yogurt bacteria, and on the contrary, they may have a positive effect on their survival and increase their number during storage [36]. This was also confirmed by the results of our research. Moreover, El-Nawawy et al. [37] reported a beneficial effect of sage extracts on the population of S. thermophilus and L. bulgaricus. On the other hand, Hołderna-Kedzia and Kedzia [51] showed a negative effect of these extracts on Lactobacillus acidophilus ATCC 4356, Lactobacillus casei ATCC 393, Lactobacillus rhamnosus Hansen 1968, Bifidobacterium bifidum ATCC 35914, S. thermophilus ATCC 14485, and Saccharomyces boulardii SB48 ATCC-MYA-796. The antibacterial effect of chamomile (M. chamomilla L.) extracts has been described in many studies [49,51,52,53]. However, there are no scientific reports on the effect of chamomile extract on LABs. Several researchers have studied the activity of cistus (Cistus L.) extract against pathogenic fungi and bacteria [54,55,56,57]. Few reports even indicate that linden blossom has a slight antibacterial effect (Tilia L.) [58,59], but there are no data on its influence on LABs. Ethanol and methanol extracts of ribwort plantain (P. lanceolata L.) have already been tested against the strains of Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Bacillus cereus, Proteus mirabilis, Pseudomonas aeruginosa, Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, Candida albicans, and Candida tropicalis and found to be active against these bacteria [60,61,62,63].
For marshmallow (Althaea L.) extracts, it has been shown that the extracts inhibited the growth of bacteria such as Pseudomonas fluorescens, P. aeruginosa, Bordetella bronchiseptica, S. aureus, S. epidermidis, Micrococcus luteus, Enterococcus faecalis, B. subtilis, B. cereus, Aspergillus niger, C. albicans, and Saccharomyces cerevisiae [64,65]. It was also showed that marshmallow extracts did not have any inhibitory effect on E. coli, K. pneumoniae, or Serratia marcescens [64]. However, the effect of these extracts on LABs has not yet been studied.

4.2. TPC and Antioxidant Capacities of Plant Extracts

It is reported that the metabolites present in plant extracts, including phenolic compounds, are responsible for their various biological activities, such as total phenolic content and antioxidant activity [20,22,66,67,68]. Therefore, it is worth analyzing the research proving the antioxidant activity of selected herbal extracts. Phenolic compounds are widespread in the world of plants. Based on the structure of the carbon skeleton, phenolic compounds can be divided into phenolic acids and flavonoids.
Wang et al. [69] and Şen and Mat [66] indicated that sesquiterpenes, iridoids, flavonoids, and alkaloids were isolated from valerian (V. officinalis L.) extracts. Katsarova et al. [67] showed the lowest antioxidant activity for valerian extracts among the eight tested plant extracts (V. officinalis, Melissa officinalis, Crataegus monogyna, Hypericum perforatum, Serratula coronata, and their two combinations): oxygen radical absorbing capacity—820.5 ± 21.9 µmol TE/g; hydroxyl radical averting capacity—381.6 ± 14.0 µmol GAE/g; and polyphenolic content—43.36 ± 1.3 mg/g. In our study, the valerian extract showed slightly less TPC, expressed as mg GAE/g extract, compared to the above value, despite the fact that its chemical composition included a large diversity of ingredients with antioxidant properties. Furthermore, compared to the other tested plant extracts, its antioxidant capacities were lower.
The crude extract of sage (S. officinalis L.) studied by Koşar et al. [70] contained hydroxybenzoic acids, hydroxycinnamic acids, flavonoids, and diterpenoids, in addition to caffeic acid, carnosic acid, luteolin, luteolin-7-O-glucoside, and rosmarinic acid. However, the composition of the plant extract may vary depending on the method used for extraction [5,71,72,73]. The sage extract obtained by Houghton [5] also contained cyclic monoterpenes, such as 1,8-cineol, α-pinene, and camphor. The crude extract and subfractions demonstrated varying degrees of antioxidant capacity. Rosmarinic acid and abietane diterpenes were thought to be responsible for the potent scavenging properties of Salvia taxa [74,75]. Our research confirmed a good correlation between the high TPC in the sage extract and its high antioxidant capacities. Modern analytical methods based on semipreparative HPLC, high-resolution MS, nuclear magnetic resonance spectroscopy, infrared spectroscopy, and single-crystal X-ray diffraction were used to analyze the chemical composition of different sage extracts obtained from the areal parts. A substantial difference was found between the composition of sage flower CO2 extract and that of sage flower resin extract [76]. In addition to the known compounds, novel compounds were identified in sage flowers. Among these, some were preidentified in our research, namely danshensu, caffeic acid, rosmarinic acid, luteolin, and apigenin.
The basic active substances of chamomile (M. chamomilla L.) include essential oils, flavonoids, coumarins, sesquiterpenes, polyacetylenes, spiroether, choline, mucus compounds, vitamin C, and mineral salts. Chamomile oil contains compounds that have a specific healing effect, such as antiallergic chamazulene and bisabolol and its oxides. Many bioactive phenolic compounds, including herniarin and umbelliferone (coumarin), chlorogenic acid and caffeic acid (phenylpropanoids), apigenin, apigenin-7-O-glucoside, luteolin and luteolin-7-O-glucoside (flavones), quercetin and rutin (flavonols), and naringenin (flavanone), have been found in chamomile extract [77,78,79]. Among flavonoids, apigenin is the most promising due to its multiple therapeutic functions. It exists in the form of various glycosides or in very small quantities as free apigenin. The method of extraction not only determines the chemical composition of chamomile extract but also its antioxidant activity [72]. Flavonoids represent the major fraction of water-soluble components in chamomile [71]. Their values in chamomile aqueous extract were established as follows: quercetin equivalent per gram of extract—27.65 ± 0.007 µg; GAE per gram of extract—146.97 ± 0.046 µg, and tannic acid equivalent per gram of extract—132.22 ± 0.023 µg. In contrast, analysis of chamomile extract containing many flavonoids and numerous organic acids and their derivatives in this study revealed the low TPC compared to other tested plant extracts tested, as well as one of the lowest antioxidant capacities.
Viapiana et al. [9] determined the content of phenolic acids and flavonoids in cistus (Cistus L.) extracts. Their results revealed that aqueous cistus extracts were richer in phenolic compounds and showed strong antioxidant activities. The total amount of polyphenols in the leaf, stalk, and bud extracts of Cistus incanus determined by Dimcheva and Karsheva [73] varied between 36.26 and 115.32 mg GAE/g dry weight (dw), depending on the time of extraction. After 180 min of C. incanus extraction, the phenolic content was slightly higher than that observed in our study. Such result has also been shown by other studies. Researchers showed that the place of origin is the main factor differentiating the antibacterial activities of cistus samples. Dimcheva et al. [10] found catechins, flavonoids, and gallic and vanillic acids in Cistus extracts. The compounds identified by Gori et al. [80] in crude ethanolic leaf extract of C. incanus included gallic acid derivatives, condensed tannins, and flavonol glycosides. In total, 19 compounds were identified based on the fragmentation of individual polyphenols and by comparing their retention times and UV/Vis spectra with authentic standards. As in our research, the presence of epicatechin, myricetin hexoside, and quercetin pentoside was found in the C. incanus extract by Gori et al. [80]. In our study, the Cistus extract had the highest TPC among the tested plant extracts, and thus showed the highest antioxidant capacities. Its composition included many organic acids and their derivatives, as well as flavonoids such as catechin, quercetin, kaempferol, and myricetin.
Several studies have been performed on linden blossom (Tilia L.) extracts. The results revealed the presence of terpenoids, quercetin, and kaempferol derivatives (such as tiliroside), phenolic compounds, esters, aliphatic acids, hydrocarbons, condensed tannins, and a coumarin scopoletin in the extracts [11,16,81,82]. Wissam et al. [83] stated that TPC and the antioxidant activity were determined in the ethanolic extracts of dried linden blossom leaves (0.3303 ± 0.0896 mg/mL calculated as DPPH scavenging activity). In our study, the DPPH value of linden blossom extract was determined as 0.161 ± 0.007, but expressed as mmol TE/g extract. This value was the second highest recorded in our experiments. TPC of the linden blossom extract was also one of the largest and resulted from the presence of quercetin, kaempferol, other flavonoids, and their derivatives, as well as many organic acids. In addition, 3,4-dihydroxybenzoic acid, myricetin, rutin, ferulic acid, and 3,4-dihydroxybenzaldehyde were found in abundance in the Tilia tomentosa flower [84]. In turn, the major phenolic compound observed in acetone and methanolic extracts of Tilia argentea was protocatechuic acid. The leaf samples of Tilia species were found to contain many compounds similar to those in flower samples, but each of these samples possessed a unique chemical profile including the percentage and type of flavonoid constituents [85].
Some scientists showed that phenolic compounds, mainly flavonoids and hydroxycinnamic acids, were the main components of hydrophilic ribwort plantain (P. lanceolata L.) extracts [19]. Galvez et al. [20] found that luteolin was biologically important among the flavonoids. According to [17], phenylethanoids, especially Aukubin, are responsible for the antimicrobial effects of ribwort plantain extracts. It was reported that these extracts exhibited a strong antioxidant activity [19]. Lukova et al. [68] studied the antioxidant activity of the ethanol extracts of P. lanceolata leaves by DPPH scavenging test, CUPRAC (cupric reducing antioxidant capacity) assay, and FRAP assay and established the following values: DPPH—59.04 ± 0.09%; CUPRAC—21.9 ± 0.58 µM TE/g dw; and FRAP—51.85 ± 1.54 µM TE/g dw. The Plantago plantain leaf extract tested in our study was characterized by an average content of TPC expressed as mg GAE/g of extract, as well as average antioxidant capacities expressed by DPPH, ABTS, or FRAP scavenging ability.
In general, marshmallow (Althaea L.) ethanol extracts show high antioxidant activity, which is due to the presence of active compounds such as flavonoids and mucus polysaccharides [22]. However, this was not confirmed by the results of our research. The leaves of marshmallow contain the coumarin scopoletin, as well as many flavonoids (hypolaetin-8-glucoside, isoquercitrin, kaempferol, caffeic acid, p-coumaric acid, ferulic acid, p-hydroxybenzoic acid, salicylic acid, p-hydroxyphenylacetic acid, vanillic acid) [86,87]. Elmastas et al. [22] indicated the strong total antioxidant activity of ethanolic marshmallow extract. They reported that the marshmallow extract showed effective reducing power, free radical scavenging activity, superoxide anion radical scavenging activity, and metal chelating ability at the same concentration (50, 100, and 250 mg/mL, respectively). In comparison, the marshmallow extract tested in our study contained only a few antioxidant substances (some flavonoids and organic acids), which resulted in its lower antioxidant capacities.

5. Conclusions

This study showed that the addition of herbal extracts from valerian (V. officinalis L.), sage (S. officinalis L.), chamomile (M. chamomilla L.), cistus (Cistus L.), linden blossom (Tilia L.), ribwort plantain (P. lanceolata L.), and marshmallow (Althaea L.) did not inhibit the growth of LAB in fermented milk drinks such as yogurts. In light of the presented results, yogurts enriched with the plant extracts tested in this study can be of interest to customers. However, these herbal extracts should be added in limited amounts because they gradually inhibit the fermentation activity. Now, knowing in what dose range dairy products fermented with the addition of selected herbal extracts can be tested in the future, including storage research. When added at concentrations above 2% by weight, which probably can be used to prevent overacidification of fermented milk after the fermentation process is complete, herbal extracts from valerian, sage, chamomile, cistus, linden blossom, ribwort plantain, or marshmallow should be tested for the storage stability of fermented milk beverages such as yoghurts containing live lactic acid bacteria.
Nevertheless, due to the antioxidant properties, a slight addition of the herbal extracts containing polyphenols to different kinds of food products can increase the nutritional quality, thus making them functional foods. The microflora of yogurts containing the tested herbal extracts did not die during digestion in model digestive juices, and this amount of bacteria surviving digestion can benefit the health of consumers. Thus, the tested plant extracts had neither an inhibitory nor a stimulating effect on bacteria in the fermented milk samples.

Author Contributions

Conceptualization, M.Z. and M.K. (Mariola Kozłowska); methodology, M.Z., M.K. (Mariola Kozłowska) and I.Ś.; investigation, M.Z., M.K. (Mariola Kozłowska), I.Ś., M.K. (Mariusz Kowalczyk), S.P., A.S. and B.S.; data curation, M.Z. and B.S.; writing—M.Z., M.K. (Mariola Kozłowska), I.Ś. and B.S.; writing—review and editing, M.Z., M.K. (Mariola Kozłowska), I.Ś. and S.P.; project administration, M.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Polish Ministry of Science and Higher Education with funds of the Warsaw University of Life Sciences WULS–SGGW (Poland).

Institutional Review Board Statement

This study did not involve humans or animals.

Informed Consent Statement

This study did not involve humans.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Goun, E.A.; Petrichenko, V.M.; Solodnikov, S.U.; Suhinina, T.V.; Kline, M.A.; Cunningham, G.; Miles, H. Anticancer and antithrombin activity of Russian plants. J. Ethnopharmacol. 2002, 81, 337–342. [Google Scholar] [CrossRef]
  2. O’Hara, M.; Kiefer, D.; Farrell, K.; Kemper, K. A review of 12 commonly used medicinal herbs. Arch. Fam. Med. 1998, 7, 523–536. [Google Scholar] [CrossRef]
  3. Woźniak, M.; Ostrowska, K.; Szymański, Ł.; Wybieralska, K.; Zielińśki, R. Aktywność przeciwrodnikowa ekstraktów szałwii i rozmarynu. Żywność 2009, 4, 133–141, (Abstract in English). [Google Scholar]
  4. Tildesley, N.T.; Kennedy, D.O.; Perry, E.K.; Ballard, C.G.; Savelev, S.A.W.K.; Wesnes, K.A.; Scholey, A.B. Salvia lavandulaefolia (Spanish Sage) enhances memory in health young volunteers. Pharmacol. Biochem. Behav. 2003, 75, 669–674. [Google Scholar] [CrossRef]
  5. Houghton, P.J. Activity and constituents of sage relevant to the potential treatment of symptoms Alzheimer’s disease. Herba Gran 2004, 61, 38–43. [Google Scholar]
  6. Khayyal, M.T.; El-Ghazaly, M.A.; Kenawy, S.A.; Seif-El-Nasr, M.; Mahran, L.G.; Kafafi, Y.A.; Okpanyi, S.N. Antiulcerogenic effect of certain plant extracts and their combinations. Arzneimittelforsch 2001, 51, 545–553. [Google Scholar]
  7. Torrado, S.; Agis, A.; Jimenez, M.E.; Cadorniga, R. Effect of dissolution profile and (−)-alpha-bisabolol on the gastrotoxicity of acetylsalicylic acid. Pharmazie 1995, 50, 141–143. [Google Scholar] [PubMed]
  8. Sebai, H.; Jabri, M.A.; Souli, A.; Rtibi, K.; Selmi, S.; Tebourbi, O.; Sakly, M. Antidiarrheal and antioxidant activities of chamomile (Matricaria recutita L.) decoction extract in rats. J. Ethnopharmacol. 2014, 152, 327–332. [Google Scholar] [CrossRef]
  9. Viapiana, A.; Konopacka, A.; Waleron, K.; Wesolowski, M. Cistus incanus L. commercial products as a good source of polyphenols in human diet. Ind. Crops Prod. 2017, 107, 297–304. [Google Scholar] [CrossRef]
  10. Dimcheva, V.; Kaloyanov, N.; Karsheva, M. The polyphenol composition of Cistus incanus L., Trachystemon orientalis L. and Melissa officinalis L. infusions by HPLC-DAD method. Open J. Anal. Bioanal. Chem. 2019, 3, 031–038. [Google Scholar] [CrossRef] [Green Version]
  11. Arcos, M.L.B.; Cremaschi, G.; Werner, S.; Coussio, J.; Ferraro, G.; Anesini, C. Tília cordata Mill. extracts and scopoletin (isolated compound): Differential cell growth effects on lymphocytes. Phytother. Res. 2006, 20, 34–40. [Google Scholar] [CrossRef]
  12. Hyun Kim, K.; Moon, E.; Kim, S.Y.; Choi, S.U.; Lee, K.R. Lignan constituents of Tilia amurensis and their biological evaluation on antitumor and anti-inflammatory activities. Food. Chem. Toxicol. 2012, 50, 3680–3686. [Google Scholar]
  13. Martinez, A.L.; Gonzalez-Trujano, M.A.; Aguirre-Hernandez, E.; Moreno, J.; Soto-Hernandez, M.; Lopez-Munoz, F.J. Antinociceptive activity of Tilia americana var. mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats. Neuropharmacology 2009, 56, 564–571. [Google Scholar] [CrossRef]
  14. Toker, G.; Küpeli, E.; Memisoğlu, M.; Yesilada, E. Flavonoids with antinociceptive and anti-inflammatory activities from the leaves of Tilia argentea (silver linden). J. Ethnopharmacol. 2004, 95, 393–397. [Google Scholar] [CrossRef]
  15. Aguirre-Hernandez, E.; Martinez, A.L.; Gonzalez-Trujano, M.A.; Moreno, J.; Vibrans, H.; Soto-Hernandez, M. Pharmacological evaluation of the anxiolytic and sedative effects of Tilia americana L. var. mexicana in mice. J. Ethnopharmacol. 2007, 109, 140–145. [Google Scholar] [CrossRef]
  16. Herrera-Ruiz, M.; Román-Ramos, R.; Zamilpa, A.; Tortoriello, J.; Jiménez-Ferrer, J.E. Flavonoids from Tilia americana with anxiolytic activity in plus-maze test. J. Ethnopharmacol. 2008, 118, 312–317. [Google Scholar] [CrossRef] [PubMed]
  17. ESCOP. Monographs 2013: European Scientific Cooperative on Phytotherapy. Plantaginis lanceolatae Folium/Herba, 2nd ed.; Ribwort Plantain Leaf/Herb; European Scientific Cooperative on Phytotherapy (ESCOP): Exeter, UK, 2013; pp. 383–387. [Google Scholar]
  18. Parus, A.; Grys, A. Plantago lanceolata L.-medicinal properties. Post Fit. 2010, 3, 162–165, (Abstract in English). [Google Scholar]
  19. Dalar, A.; Türker, M.; Konczak, I. Antioxidant capacity and phenolic constituents of Malva neglecta Wallr. and Plantago lanceolata L. from Eastern Anatolia Region of Turkey. J. Herbal Med. 2012, 2, 42–51. [Google Scholar] [CrossRef]
  20. Galvez, M.; Martí, C.; Lopez-Lazaro, M.; Cortes, F.; Ayuso, J. Cytotoxic effect of Plantago spp. on cancer cell lines. J. Ethnopharmacol. 2003, 88, 125–130. [Google Scholar] [CrossRef]
  21. Deters, A.; Zippel, J.; Hellenbrand, N.; Pappai, D.; Possemeyer, C.; Hensel, A. Aqueous extracts and polysaccharides from Marshmallow roots (Althea officinalis L.): Cellular internalisation and stimulation of cell physiology of human epithelial cells in vitro. J. Ethnopharmacol. 2010, 127, 62–69. [Google Scholar] [CrossRef] [PubMed]
  22. Elmastas, M.; Ozturk, L.; Gokce, I.; Erenler, R.; Aboul Enein, H.Y. Determination of antioxidant activity of marshmallow flower (Althaea officinalis L.). Anal. Lett. 2004, 37, 1859–1869. [Google Scholar] [CrossRef]
  23. Izzo, A.A.; Di Carlo, G.; Mascolo, N.; Autore, G.; Capasso, F. Antiulcer effect of flavonoids. Role of endogenous PAF. Phytother. Res. 1994, 29, 87–93. [Google Scholar] [CrossRef]
  24. Guerrero, J.A.; Lozano, M.L.; Castillo, J.; Benavente Garcia, O.; Vicente, V.; Rivera, J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J. Thromb. Haemost. 2005, 3, 369–376. [Google Scholar] [CrossRef] [PubMed]
  25. Kozłowska, M.; Ścibisz, I.; Zaręba, D.; Ziarno, M. Antioxidant properties and effect on lactic acid bacterial growth of spice extracts. CyTA 2015, 13, 573–577. [Google Scholar] [CrossRef] [Green Version]
  26. Kozłowska, M.; Ziarno, M.; Rudzińska, M.; Tarnowska, K.; Majewska, E.; Kowalska, D. Skład chemiczny olejku eterycznego z kolendry i jego wpływ na wzrost wybranych szczepów bakterii kwasu mlekowego. Żywność 2018, 25, 97–111, (Abstract in English). [Google Scholar] [CrossRef]
  27. Ziarno, M.; Zaręba, D. Effects of milk components and food additives on survival of three bifidobacteria strains in fermented milk under simulated gastrointestinal tract conditions. Microb. Ecol. Health Dis. 2015, 26. [Google Scholar] [CrossRef] [PubMed]
  28. Singleton, V.L.; Rossi, J.A. Colorimetry of total phenolics with phosphomolybdic-phodphotonegstics acid reagents. Am. J. Enol. Viticult. 1965, 16, 144–158. [Google Scholar]
  29. Yen, G.C.; Chen, H.Y. Antioxidant activity of various tea extracts in relation to their antimutagenicity. J. Agric. Food Chem. 1995, 43, 27–32. [Google Scholar] [CrossRef]
  30. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Rad. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
  31. Benzie, I.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef] [Green Version]
  32. Dührkop, K.; Fleischauer, M.; Ludwig, M.; Aksenov, A.A.; Melnik, A.V.; Meusel, M.; Dorrestein, P.C.; Rousu, J.; Böcker, S. SIRIUS 4: A rapid tool for turning tandem mass spectra into metabolite structure information. Nat. Methods 2019, 16, 299–302. [Google Scholar] [CrossRef] [Green Version]
  33. Rodríguez, H.; Curiel, J.A.; Landete, J.M.; de las Rivas, B.; de Felipe, F.L.; Gómez-Cordovés, C.; Mancheño, J.M.; Muñoz, R. Food phenolics and lactic acid bacteria. Int. J. Food Microbiol. 2009, 132, 79–90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Landete, J.M.; Rodríguez, H.; Curiel, J.A.; de las Rivas, B.; Mancheño, J.M.; Muñoz, R. Gene cloning, expresión, and characterization of phenolic acid decarboxylase from Lactobacillus brevis RM84. J. Ind. Microbiol. Biotechnol. 2010, 37, 617–624. [Google Scholar] [CrossRef] [Green Version]
  35. Takagaki, A.; Nanjo, F. Metabolism of (−)-epigallocatechin gallate by rat intestinal flora. J. Agric. Food Chem. 2010, 58, 1313e1321. [Google Scholar] [CrossRef]
  36. Otaibi, M.A.; Demerdash, H.E. Improvement of the quality and shelf life of concentrated yoghurt (labneh) by the addition of some essential oils. Afr. J. Microbiol. Res. 2008, 2, 156–161. [Google Scholar]
  37. El-Nawawy, M.A.; El-Kenany, Y.M.; Abd El-Ghaffar, E.A. Effect of some herb plants on the use of yoghurt culture. Ann. Agric. Sci. 1998, 7, 15–17. [Google Scholar]
  38. Zaręba, D.; Ziarno, M.; Strzelczyk, B. Przeżywalność bakterii fermentacji mlekowej w warunkach modelowych jelita cienkiego. Żywność 2008, 15, 197–205, (Abstract in English). [Google Scholar]
  39. Ziarno, M.; Margol, B. Research into the Ability of Some Selected Starter Lactic Acid Bacteria (Slab) to Survive in a Model Gastric Juice and Cholesterol Binding Under Those These Conditions. Żywność 2007, 6, 304–314, (Abstract in English). [Google Scholar]
  40. Al-Turki, A.I.; El-Ziney, M.G.; Abdel-Salam, A.M. Chemical and anti-bacterial characterization of aqueous extracts of oregano, marjoram, sage and licorice and their application in milk and labneh. J. Food Agric. Environ. 2008, 6, 39–44. [Google Scholar]
  41. Nes, I.F.; Skjelkvale, R. Effect of natural spices and oleoresins on Lactobacillus plantarum in the fermentation of dry sausage. J. Food Sci. 1982, 47, 1618–1625. [Google Scholar] [CrossRef]
  42. Kivanç, M.; Akgül, A.; Doǧan, A. Inhibitory and stimulatory effects of cumin, oregano and their essential oils on growth and acid production of Lactobacillus plantarum and Leuconostoc mesenteroides. Int. J. Food Microbiol. 1991, 13, 81–85. [Google Scholar] [CrossRef]
  43. Michael, M.; Phebus, R.K.; Schmidt, K.A. Impact of a plant extract on the viability of Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus in nonfat yogurt. Int. Dairy J. 2010, 20, 665–672. [Google Scholar] [CrossRef]
  44. Yangmei, Q.; Jiang, W.; Hou, H.; Zhang, H. Application of Plant Green Juice Powder in Maintaining Stability of Viable Count of Yoghourt in Shelf Life. Patent No. CN 102106386 B, 22 March 1991. [Google Scholar]
  45. China, R.; Mukherjee, S.; Sen, S.; Bose, S.; Datta, S.; Koley, H.; Dhar, P. Antimicrobial activity of Sesbania grandiflora flower polyphenol extracts on some pathogenic bacteria and growth stimulatory effect on the probiotic organism Lactobacillus acidophilus. Microbiol. Res. 2012, 167, 500–506. [Google Scholar] [CrossRef] [PubMed]
  46. Dimitrova, M.; Ivanov, G.; Mihalev, K.; Slavchev, A.; Ivanova, I.; Vlaseva, R. Investigation of antimicrobial activity of polyphenol-enriched extracts against probiotic lactic acid bacteria. Food Sci. Appl. Biotechnol. 2019, 2, 67–73. [Google Scholar] [CrossRef]
  47. Letchamo, W.; Ward, W.; Heard, B.; Heard, D. Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. J. Agric. Food Chem. 2004, 52, 3915–3919. [Google Scholar] [CrossRef] [PubMed]
  48. Hać-Szymańczuk, E.; Lipińska, E.; Błażejak, S.; Bieniak, K. Ocena aktywności przeciwbakteryjnej szałwii lekarskiej (Salvia officinalis L.). Brom. Chem. Toksykol. 2011, 44, 667–672, (Abstract in English). [Google Scholar]
  49. Kędzia, A.; Dera-Tomaszewska, B.; Ziółkowska-Klinkosz, M.; Kędzia, A.W.; Wojtaszek-Słomińska, A.; Czernecka, B. Działanie olejku szałwiowego (Oleum Salviae lavandulaefoliae) na bakterie tlenowe izolowane z jamy ustnej, dróg oddechowych i przewodu pokarmowego. Post. Fitoter. 2011, 1, 238–242, (Abstract in English). [Google Scholar]
  50. Gniewosz, M.; Kraśniewska, K.; Węglarz, Z.; Przybył, J.L. Porównanie przeciwdrobnoustrojowej aktywności etanolowego i wodnego ekstraktu z szałwii lekarskiej (Salvia officinalis L.). Brom. Chem. Toksykol. 2012, 45, 743748, (Abstract in English). [Google Scholar]
  51. Hołderna-Kędzia, E.; Kędzia, B. Działanie preparatów pochodzenia roślinnego na drobnoustroje probiotyczne. Post. Fitoter. 2012, 1, 72–77, (Abstract in English). [Google Scholar]
  52. Grys, A.; Kania, M.; Baraniak, J. Rumianek—Pospolita roślina zielarska o różnorodnych właściwościach biologicznych i leczniczych. Post. Fitoter. 2014, 1, 90–93, (Abstract in English). [Google Scholar]
  53. Roby, M.H.H.; Sarhan, M.A.; Selim, K.A.H.; Khalel, K.I. Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare L.) and chamomile (Matricaria chamomilla L.). Ind. Crops Prod. 2013, 44, 437–445. [Google Scholar] [CrossRef]
  54. Ustün, O.; Ozçelik, B.; Akyön, Y.; Abbasoglu, U.; Yesilada, E. Flavonoids with anti-Helicobacter pylori activity from Cistus laurifolius leaves. J. Ethnopharmacol. 2006, 108, 457–461. [Google Scholar] [CrossRef]
  55. Hutschenreuther, A.; Birkemeyer, C.; Grötzinger, K.; Straubinger, R.K.; Rauwald, H.W. Growth inhibiting activity of volatile oil from Cistus creticus L. against Borrelia burgdorferi in vitro. Pharmazie 2010, 65, 290–295. [Google Scholar] [PubMed]
  56. Tomás, M.L.; Morales-Soto, A.; Barrajón-Catalán, E.; Roldán-Segura, C.; Segura-Carretero, A.; Micol, V. Correlation between the antibacterial activity and the composition of extracts derived from various Spanish Cistus species. Food. Chem. Toxicol. 2013, 55, 313–322. [Google Scholar] [CrossRef]
  57. Rebaya, A.; Belghith, S.I.; Hammrouni, S.; Maaroufi, A.; Ayadi, M.T.; Chérif, J.K. Antibacterial and Antifungal Activities of Ethanol Extracts of Halimium halimifolium, Cistus salviifolius and Cistus monspeliensis. Int. J. Pharm. Clin. Res. 2016, 8, 243–247. [Google Scholar]
  58. Gönül, Ş.E.A.; Karapinar, M. Inhibitory effect of linden flower (Tilia flower) on the growth of foodborne pathogens. Food Microbiol. 1987, 4, 97–100. [Google Scholar] [CrossRef]
  59. Yıldırım, A.; Mavi, A.; Oktay, M.; Kara, A.A.; Algur, Ö.F.; Bilaloǧlu, V. Comparison of antioxidant and antimicrobial activities of Tilia (Tilia argentea Desf ex DC), sage (Salvia triloba L.), and Black tea (Camellia sinensis) extracts. J. Agric. Food Chem. 2000, 48, 5030–5034. [Google Scholar] [CrossRef]
  60. Sharifa, A.A.; Neoh, Y.L.; Iswadi, M.I.; Khairul, O.; Abdul Halim, M.; Jamaludin, M.; Hing, H.L. Effects of methanol, ethanol and aqueous extract of Plantago major on gram positive bacteria, gram negative bacteria and yeast. Ann. Micr. 2008, 8, 42–44. [Google Scholar]
  61. Kahyaoğlu, M.; Türkoğlu, İ. Antimicrobial activities of some plants collected in Elazığ region. Dumlupinar Univ. Bilim. Enst. Derg. 2008, 15, 1–8. [Google Scholar]
  62. Ferrazzano, G.F.; Cantile, T.; Roberto, L.; Ingenito, A.; Catania, M.R.; Roscetto, E.; Pollio, A. Determination of the in vitro and in vivo antimicrobial activity on salivary Streptococci and Lactobacilli and chemical characterisation of the phenolic content of a Plantago lanceolata infusion. BioMed Res. Int. 2015, 2015, 286817. [Google Scholar] [CrossRef] [Green Version]
  63. Metiner, K.; Ozkan, O.; Ak, S. Antibacterial effects of ethanol and acetone extract of Plantago major L. on Gram positive and Gram negative bacteria. Kafkas Univ. Vet. Fak. Derg. 2012, 18, 503–505. [Google Scholar]
  64. Bonjar, S. Evaluation of antibacterial properties of some medicinal plants used in Iran. J. Ethnopharmacol. 2004, 94, 301–305. [Google Scholar] [CrossRef]
  65. Valiei, M.; Shafaghat, A.; Salimi, F. Chemical composition and antimicrobial activity of the flower and root hexane extracts of Althaea officinalis in Northwest Iran. J. Med. Plants Res. 2011, 5, 6972–6976. [Google Scholar]
  66. Şen, B.; Mat, A. Chemical and medicinal evaluations of the Valeriana species in Turkey. J. Fac. Pharm. İstanbul Üniv. 2015, 45, 267–276. [Google Scholar]
  67. Katsarova, M.; Dimitrova, S.; Lukanov, L.; Sadakov, F.; Denev, F.; Plotnikov, E.; Kandilarov, I.; Kostadinova, I. Antioxidant activity and nontoxicity of extracts from Valeriana officinalis, Melissa officinalis, Crataegus monogyna, Hypericum perforatum, Serratula coronata and combinations Antistress 1 and Antistress 2. Bulg. Chem. Commun. 2017, 49, 93–98. [Google Scholar]
  68. Lukova, P.; Karcheva-Bahchevanska, D.; Dimitrova-Dyulgerova, I.; Katsarov, P.; Mladenov, R.; Iliev, I.; Nikolova, M. A comparative pharmacognostic study and assessment of antioxidant capacity of three species from Plantago genus. Farmacia 2018, 66, 609–614. [Google Scholar] [CrossRef]
  69. Wang PCh Ran, X.H.; Luo, R.H.; Ma, Q.Y.; Liu, Y.Q.; Zhoum, J.; Zhao, Y.X. Phenolic Compounds from the Roots of Valeriana officinalis var. latifolia. J. Braz. Chem. Soc. 2013, 24, 1544–1548. [Google Scholar] [CrossRef]
  70. Koşar, M.; Dorman, H.J.D.; Hüsnü Can Başer, K.; Hiltunen, R. Salvia officinalis L.: Composition and Antioxidant-related Activities of a Crude Extract and Selected Sub-fractions. Nat. Prod. Commun. 2010, 9, 1453–1456. [Google Scholar] [CrossRef] [Green Version]
  71. Seddik, K.; Dalila, B.; Saliha, D.; Saliha, D.; Smain, A.; Noureddine, C.; Abderahmane, B.; Daoud, H.; Lekhmici, A. Polyphenols and antioxidant properties of extracts from Mentha pulegium L. and Matricaria chamomilla L. Pharm. Commun. 2013, 3, 35–40. [Google Scholar] [CrossRef]
  72. Ranjbar, A.; Mohsenzade, F.; Chehregani, A.; Khajavi, F.; Sifpanahi, H. Antioxidant capacity of various extracts of Matricaria Chamomilla, L. parts. Compl. Med. J. 2015, 4, 1022–1027. [Google Scholar]
  73. Dimcheva, V.; Karsheva, M. Cistus incanus from Strandja Mountain as a source of bioactive antioxidants. Plants 2018, 7, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Lu, Y.; Foo, L.Y. Antioxidant activities of polyphenols from sage (Salvia officinalis). Food Chem. 2001, 75, 197–202. [Google Scholar] [CrossRef]
  75. Koşar, M.; Dorman, H.J.D.; Baser, K.H.C.; Hiltunen, R. An improved HPLC post-column methodology for the identification of free radical scavenging phytochemicals in complex mixtures. Chromatographia 2004, 60, 635–638. [Google Scholar] [CrossRef]
  76. Gericke, S.; Lübken, T.; Wolf, D.; Kaiser, M.; Hannig, C.; Speer, K. Identification of new compounds from sage flowers (Salvia officinalis L.) as markers for quality control and the influence of the manufacturing technology on the chemical composition and antibacterial activity of sage flower extracts. J. Agric. Food Chem. 2018, 66, 1843–1853. [Google Scholar] [CrossRef]
  77. Redaelli, C.; Formentini, L.; Santaniello, E. PLC determination of coumarins in Matricaria chamomilla. Planta Med. 1981, 43, 412–413. [Google Scholar] [CrossRef]
  78. Ohe, C.; Miami, M.; Hasegawa, C.; Ashida, K.; Sugino, M.; Kanamori, H. Seasonal variation in the production of the head and accumulation of glycosides in the head of Matricaria chamomilla. Acta Hortic. 1995, 390, 75–82. [Google Scholar] [CrossRef]
  79. Gupta, V.; Mittal, P.; Bansal, P.; Khokra, S.L.; Kaushik, D. Pharmacological potential of Matricaria recutita—A review. Int J. Pharm. Sci. Drug Res. 2010, 2, 12–16. [Google Scholar]
  80. Gori, A.; Ferrini, F.; Marzano, M.A.; Tattini, M.; Centritto, M.; Baratto, M.C.; Pogni, R.; Brunetti, C. Characterisation and antioxidant activity of crude extract and polyphenolic rich fractions from C. incanus leaves. Int. J. Mol. Sci. 2016, 17, 1344. [Google Scholar] [CrossRef] [PubMed]
  81. Pietta, P.; Facino, R.M.; Carini, M.; Mauri, P. Thermospray liquid chromatography mass spectrometry of flavonol glycosides from medicinal plants. J. Chrom. A 1994, 661, 121–126. [Google Scholar] [CrossRef]
  82. Behrens, A.; Maie, N.; Knicker, H.; Kogel-Knabner, I. MALDI-TOF mass spectrometry and PSD fragmentation as means for the analysis of condensed tannins in plant leaves and needles. Phytochemistry 2003, 62, 1159–1170. [Google Scholar] [CrossRef]
  83. Wissam, Z.; Nour, A.A.; Bushra, J.; Zein, N.; Saleh, D. Extracting and studying the antioxidant capacity of polyphenols in dry linden leaves (Tilia cordata). J. Pharm. Phytochem. 2017, 6, 258–262. [Google Scholar]
  84. Kivrak, Ş.; Göktürk, T.; Kivrak, I. Determination of phenolic composition of Tilia Tomentosa flowers using UPLC-ESI-MS/MS. Int. J. Sec. Metab. 2017, 4, 249–256. [Google Scholar] [CrossRef]
  85. Ashour, M.A.-G. Practical authentication and quality control of Tilia flos. Int. J. Biol. Pharm. Appl. Sci. 2017, 6, 1122–1156. [Google Scholar]
  86. Gudej, J. Flavonoids, phenolic acids and coumarins from the roots of Althaea officinalis. Planta Med. 1991, 57, 284–285. [Google Scholar] [CrossRef] [PubMed]
  87. Shah, S.M.A.; Akhtar, N.; Akram, M.; Shah, P.A.; Saeed, T.; Ahmed, K.; Asif, H.M. Pharmacological activity of Althaea officinalis L. J. Med. Plants Res. 2011, 5, 5662–5666. [Google Scholar]
Figure 1. The effect of plant extracts on lactic acid fermentation (average values and standard deviations of three replicates): (a) valerian (Valeriana officinalis L.); (b) sage (Salvia officinalis L.); (c) chamomile (Matricaria chamomilla L.); (d) cistus (Cistus L.); (e) linden blossom (Tilia L.); (f) ribwort plantain (Plantago lanceolata L.); and (g) marshmallow (Althaea L.).
Figure 1. The effect of plant extracts on lactic acid fermentation (average values and standard deviations of three replicates): (a) valerian (Valeriana officinalis L.); (b) sage (Salvia officinalis L.); (c) chamomile (Matricaria chamomilla L.); (d) cistus (Cistus L.); (e) linden blossom (Tilia L.); (f) ribwort plantain (Plantago lanceolata L.); and (g) marshmallow (Althaea L.).
Applsci 11 03898 g001aApplsci 11 03898 g001b
Figure 2. UHPLC-QTOF-CAD chromatograms of the studied plant extracts: (a) valerian (Valeriana officinalis L.); (b) sage (Salvia officinalis L.); (c) chamomile (Matricaria chamomilla L.); (d) cistus (Cistus L.); (e) linden blossom (Tilia L.); (f) ribwort plantain (Plantago lanceolata L.); and (g) marshmallow (Althaea L.).
Figure 2. UHPLC-QTOF-CAD chromatograms of the studied plant extracts: (a) valerian (Valeriana officinalis L.); (b) sage (Salvia officinalis L.); (c) chamomile (Matricaria chamomilla L.); (d) cistus (Cistus L.); (e) linden blossom (Tilia L.); (f) ribwort plantain (Plantago lanceolata L.); and (g) marshmallow (Althaea L.).
Applsci 11 03898 g002
Table 1. The effect of plant extracts on the populations of lactic acid bacteria (average values and standard deviations of five replicates).
Table 1. The effect of plant extracts on the populations of lactic acid bacteria (average values and standard deviations of five replicates).
Plant ExtractsSampling TimeAdditive LevelAdditive Level
0.2%0.6%1.0%1.4%2.0%3.0%0.2%0.6%1.0%1.4%2.0%3.0%
Streptococcus thermophilus Population
[log CFU/mL]
Lactobacillus delbrueckii subsp. bulgaricus Population
[log CFU/mL]
Valerian
(Valeriana officinalis L.)
after fermentation7.9 ± 0.3 a7.6 ± 0.5 a7.8 ± 0.3 a7.8 ± 0.3 a7.6 ± 0.3 a7.4 ± 0.3 a7.2 ± 0.3 a7.1 ± 0.5 a7.0 ± 0.5 a7.0 ± 0.3 a6.6 ± 0.3 a6.4 ± 0.3 a
after digestion6.6 ± 0.3 b6.5 ± 0.3 b7.0 ± 0.3 b6.8 ± 0.3 b6.5 ± 0.3 b6.3 ± 0.3 b6.7 ± 0.3 a6.5 ± 0.3 a6.8 ± 0.3 a6.9 ± 0.4 a6.5 ± 0.3 a6.1 ± 0.3 a
Sage
(Salvia officinalis L.)
after fermentation7.8 ± 0.3 a8.0 ± 0.3 a7.7 ± 0.4 a7.9 ± 0.2 a7.7 ± 0.3a7.3 ± 0.4 a,b7.2 ± 0.3a6.7 ± 0.3 a,b6.4 ± 0.3 b6.4 ± 0.3 b6.4 ± 0.3 b6.5 ± 0.3 a,b
after digestion6.9 ± 0.3 b7.0 ± 0.2 b6.3 ± 0.3 b,c6.8 ± 0.3 b,c6.6 ± 0.3 b,c6.2 ± 0.3 c6.8 ± 0.3 a,b6.3 ± 0.4 b6.2 ± 0.4 b6.2 ± 0.4 b6.1 ± 0.3 b6.1 ± 0.3 b
Chamomile
(Matricaria chamomilla L.)
after fermentation7.9 ± 0.3 a7.9 ± 0.3 a8.0 ± 0.3 a7.9 ± 0.3 a7.7 ± 0.3 a7.5 ± 0.3 a7.2 ± 0.4 a7.0 ± 0.5 a6.8 ± 0.5 a6.8 ± 0.3 a6.5 ± 0.3 a6.4 ± 0.3 a
after digestion6.8 ± 0.3 b6.3 ± 0.3 b6.9 ± 0.3 b6.9 ± 0.3 b6.5 ± 0.3 b6.3 ± 0.3 b6.6 ± 0.4 a6.3 ± 0.4 a6.6 ± 0.4 a6.7 ± 0.4 a6.5 ± 0.5 a6.2 ± 0.4 a
Cistus
(Cistus L.)
after fermentation8.1 ± 0.3 a8.0 ± 0.3 a7.9 ± 0.3 a8.0 ± 0.3 a7.8 ± 0.3 a,b7.4 ± 0.4 a,b7.2 ± 0.5 a7.2 ± 0.3 a7.2 ± 0.3 a7.6 ± 0.3 a7.2 ± 0.3 a6.8 ± 0.3 a
after digestion7.9 ± 0.4 a7.8 ± 0.4 a,b7.8 ± 0.4 a,b7.5 ± 0.3 a,b7.6 ± 0.3 a,b7.1 ± 0.2 b6.7 ± 0.4 a7.0 ± 0.4 a7.0 ± 0.4 a7.5 ± 0.4 a7.0 ± 0.4 a6.6 ± 0.4 a
Linden blossom
(Tilia L.)
after fermentation8.2 ± 0.3 a8.3 ± 0.3 a8.3 ± 0.3 a8.2 ± 0.3 a7.9 ± 0.5 a7.8 ± 0.5 a7.5 ± 0.4 a7.7 ± 0.3 a7.2 ± 0.3 a7.5 ± 0.3 a7.3 ± 0.3 a6.9 ± 0.3 a,b
after digestion6.9 ± 0.3 b6.8 ± 0.3 b6.9 ± 0.3 b6.8 ± 0.3 b6.6 ± 0.3 b6.4 ± 0.3 b7.0 ± 0.3 a6.8 ± 0.3 a,b7.0 ± 0.3 a6.7 ± 0.3 a,b6.7 ± 0.3 a,b6.3 ± 0.3 b
Ribwort plantain
(Plantago lanceolata L.)
after fermentation8.1 ± 0.3 a8.1 ± 0.4 a8.3 ± 0.3 a8.3 ± 0.3 a7.9 ± 0.2 a7.5 ± 0.5 a,b7.3 ± 0.5 a7.1 ± 0.3 a7.1 ± 0.3 a7.3 ± 0.3 a7.2 ± 0.3 a6.8 ± 0.3 a
after digestion7.1 ± 0.3 b6.7 ± 0.3 b,c6.6 ± 0.3 b,c6.5 ± 0.3 b,c6.5 ± 0.3 b,c6.2 ± 0.3 c7.0 ± 0.4 a6.7 ± 0.3 a7.0 ± 0.4 a7.2 ± 0.3 a6.8 ± 0.3 a6.5 ± 0.3 a
Marshmallow
(Althaea L.)
after fermentation8.2 ± 0.3 a8.1 ± 0.3 a8.0 ± 0.3 a8.0 ± 0.3 a7.8 ± 0.3 a7.4 ± 0.2 a7.7 ± 0.5 a7.4 ± 0.3 a7.5 ± 0.4 a7.8 ± 0.3 a7.4 ± 0.3 a7.0 ± 0.3 a,b
after digestion7.2 ± 0.3 a,b7.2 ± 0.3 a,b7.2 ± 0.3 a,b7.3 ± 0.3 a7.1 ± 0.3 a,b6.8 ± 0.3 b7.2 ± 0.3 a7.1 ± 0.3 a,b7.1 ± 0.3 a,b7.3 ± 0.3 a7.0 ± 0.3 a,b6.6 ± 0.3 b
a,b,c the same letter indices within a given bacterial species and for a given plant extract mean no statistically significant differences at the significance level of 0.05.
Table 2. The TPC and Trolox equivalent antioxidant capacity of plant extracts determined by DPPH, ABTS, and FRAP assays (average values and standard deviations of three replicates).
Table 2. The TPC and Trolox equivalent antioxidant capacity of plant extracts determined by DPPH, ABTS, and FRAP assays (average values and standard deviations of three replicates).
Plant ExtractsTotal Phenolic Content
[mg GAE/g of Extract]
Antioxidant Capacities
[mmol TE/g Extract]
DPPHABTSFRAP
Valerian (Valeriana officinalis L.)30.97 ± 0.49 f0.104 ± 0.003 b0.159 ± 0.003 b0.090 ± 0.004 a
Sage (Salvia officinalis L.)61.42 ± 0.43 c0.137 ± 0.002 c0.186 ± 0.004 c0.122 ± 0.004 b,c
Chamomile (Matricaria chamomilla L.)32.56 ± 0.24 e0.099 ± 0.003 b0.120 ± 0.003 a0.092 ± 0.004 a
Cistus (Cistus L.)106.38 ± 0.01 a0.154 ± 0.005 d0.208 ± 0.004 d0.136 ± 0.003 d
Linden blossom (Tilia L.)104.72 ± 0.39 b0.161 ± 0.007 d0.210 ± 0.007 d0.133 ± 0.004 c,d
Ribwort plantain (Plantago lanceolata L.)41.84 ± 0.20 d0.129 ± 0.004 c0.150 ± 0.003 b0.113 ± 0.006 b
Marshmallow (Althaea L.)24.06 ± 0.34 g0.084 ± 0.003 a0.123 ± 0.005 a0.098 ± 0.007 a
Different letters (a–g) within the same column indicate significant difference at the significance level of 0.05.
Table 3. Compounds identified in the valerian (Valeriana officinalis L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 3. Compounds identified in the valerian (Valeriana officinalis L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4255.0510
449.1298
-
-
255(100), 193(10)
221(100)
C11H11O7
C18H25O13
0.2
0.6
13.2
43.8
piscidic acid
unidentified
21.8361.1504-361(100), 199(5)C16H25O9−0.111.3unidentified
32.5351.0717-191(100), 215(11)C16H15O91.320.1caffeoylquinic acid (quinone form)
42.7353.0873-173(100), 191(64), 179(45)C16H17O91.411.0neochlorogenic acid
53.5553.1929-391(100), 195(21)C26H33O13−0.427.4unidentified hexoside (lignan)
64.2697.2346
553.1916
-
-
373(100), 535(14), 181(11)
391(100), 195(62)
C32H41O17
C26H33O13
0.4
1.9
15.4
118.8
hydroxypinoresinol di-hexoside
unidentified hexoside (lignan)
75.0681.2390-357(100)C32H41O161.52.6pinoresinol di-hexoside
85.5637.2348-197(100), 221(52), 341(31)C27H41O170.210.4kanokoside C isomer
95.7535.1814-373(100), 181(45)C26H31O121.44.8hydroxypinoresinol hexoside
106.1493.2285-493(100), 331(47)C22H37O121.116.2rhodioloside isomer
117.3519.1869-357(100), 151(8)C26H31O110.67.1pinoresinol hexoside
127.8609.1822
457.1709
-
-
301(100)
293(100)
C28H33O15
C21H29O11
0.5
1.4
22.0
76.6
hesperidin isomer
unidentified
138.5345.1552
347.1708
-
-
345(100)
347(100)
C16H25O8
C16H27O8
0.7
1.1
4.4
30.1
uidentified monoterpene hexoside (iridoid)
uidentified monoterpene hexoside (iridoid)
148.9477.2339-477(100), 315(35)C22H37O110.56.4unidentified monoterpene diglycoside
1510.8573.2553-573(100), 231(4)C27H41O13−0.12.3unidentified
1615.3249.1488-249(100), 163(4)C15H21O33.40.7valerenolic acid
1718.8291.1592-291(100), 249(19)C17H23O43.43.1acetylvalerenolic acid
Table 4. Compounds identified in the sage (Salvia officinalis L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 4. Compounds identified in the sage (Salvia officinalis L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4197.0458-179(53), 135(24), 123(23), 195(6), 151(4)C9H9O5−1.310.2danshensu isomer
22.8325.0933-179(100), 135(14)C15H17O8−1.911.8caffeic acid-deoxyhexoside
33.9389.1789+227(100), 209(98), 191(56), 131(12)C18H29O94.313.8unidentified
44.1355.1041
583.2047
-
-
295(100), 265(51), 160(17), 193(16), 175(10)
373(100), 361(98), 298(58), 295(33), 313(27)
C16H19O9
C27H35O14
−1.9
−2.5
19.8
12.4
ferulic acid-hexoside
unidentified
54.5493.0628-299(100), 271(50), 241(9)C21H17O14−0.912.2unidentified
64.6227.1275+209(100), 191(87), 149(55), 167(43), 131(41)C12H19O41.40.6unidentified
75.7461.0731-285(100), 255(33)C21H17O12−1.21.5luteoline-oxyhexoside
85.9593.1522
447.0938
-
-
285(100), 339(12), 255(5)
284(100), 256(7)
C27H29O15
C21H19O11
−1.7
−1.1
6.5
2.4
luteoline-hexoside-deoxyhexoside
luteoline-hexoside
96.4551.1770-235(100), 533(88), 295(69), 160(64)C26H31O130.120.5unidentified
106.8577.1200-269(100)C26H25O15−0.211.6apigenin-hexoside-deoxyhexoside
117.0445.0779-269(100)C21H17O11−0.69.0apigenin-oxyhexoside
127.1431.0984-268(100)C21H19O100.03.3apigenin-hexoside
137.2359.0768-161(100), 197(77), 179(32)C18H15O81.14.3rosmarinic acid
147.3555.1141 359(100), 161(22), 135(16), 193(14)C27H23O130.77.9salvianolic acid K isomer
157.5475.0881-284(100), 299(61)C22H19O120.224.7hispiludin/diosmetin-oxyhexoside
167.7463.1224
609.1771
+
+
301(100)
301(100), 463(4)
C22H23O11
C35H29O10
2.3
−2.7
8.8
44.0
kaempferide-hexoside
kaempferide-hexoside-deoxyhexoside
178.2769.1637-285(100), 255(26), 575(4)C36H33O19−2.122.5luteolin-oxyhexoside-pentoside-ferulic acid
189.3753.1679
621.1842
-269(100), 486(7), 193(4)
313(100), 297(44)
C36H33O18
C29H33O15
−0.9
−2.7
18.8
14.2
apigenin-oxyhexoside-pentoside-ferulic acid
unidentified
1910.2711.3968-503(100), 453(10)C37H59O13−1.019.4unidentified
2012.4493.1140-359(100), 323(40), 135(21), 179(16), 295(14)C26H21O100.013.0unidentified
2113.0327.2178-327(100), 211(12), 229(5), 171(3)C18H31O5−0.36.2unidentified
2220.3329.1760-285(100)C20H25O4−0.413.3carnosol isomer
2322.9331.1926-287(100)C20H27O4−3.311.9carnosoic acid isomer
Table 5. Compounds identified in the chamomile (Matricaria chamomilla L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 5. Compounds identified in the chamomile (Matricaria chamomilla L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4315.0719
329.0874
-
-
315(100), 152(10)
167(100), 329(28)
C13H15O9
C14H17O9
0.7
1.2
3.8
18.3
protocatechuoyl-hexoside
vanilic acid-hexoside
21.7353.0877-191(100), 179(40), 135(30)C16H17O90.21.6chlorogenic acid
32.5353.0875-191(100)C16H17O91.07.7caffeoylqunic acid
42.7353.0874-191(100), 173(83)C16H17O91.34.5caffeoylqunic acid
53.7355.1035
515.1201
-
-
193(100), 149(44)
353(100), 191(59), 179(22), 135(12)
C16H19O9
C25H23O12
0.0
−1.2
5.5
34.5
ferulic acid hexoside
dicaffeoylqunic acid
64.0639.1564-313(100), 477(53), 270(36)C28H31O170.411.4isorhamnetin-di-hexoside
74.4479.0834
609.1464
-
-
317(100), 287(10), 165(6)
284(100), 447(38)
C21H19O13
C27H29O16
−0.7
−0.4
15.1
28.5
myricetin-oxyhexoside
luteolin-di-hexoside
84.7367.1037
463.0883
-
-
367(100), 173(19), 193(9), 134(7)
300(100), 227(8)
C17H19O9
C21H19O12
−0.6
−0.2
6.5
9.7
feruloylquinic acid
quercetin- hexoside
94.8609.1469-301(100)C27H29O16−1.35.3quercetin-hexoside-deoxyhexoside
105.3355.1039-193(100), 149(27)C16H19O9−1.39.5ferulic acid hexoside
115.9593.1516
447.0937
-
-
285(100)
284(100)
C27H29O15
C21H19O11
−0.6
−1.0
5.0
3.7
kaempferol-hexoside-deoxyhexoside
kaempferol-hexoside
126.2493.1002-331(100), 287(83), 315(55)C22H21O13−2.96.4petuletin-hexoside
136.2467.1679-323(100), 305(66), 189(25)C26H27O86.828.6unidentified
146.4623.1624
515.1201
-
-
315(100), 300(88), 271(28)
353(100), 191(36), 179(26), 135(11)
C28H31O16
C25H23O12
−1.1
−1.3
29.1
5.4
isorhamnetin-hexoside-deoxyhexoside
dicaffeoylqunic acid
156.5681.1674
515.1202
-313(100), 270(45), 519(27), 477(24)
353(100), 191(71), 179(25)
C30H33O18
C25H23O12
−0.3
−1.3
13.3
25.4
isorhamnetin-hexoside-acylhexoside
dicaffeoylqunic acid
167.1431.0991-268(100)C21H19O10−1.67.7apigenin-hexoside
177.3515.1204
445.1727
-
-
353(100), 179(18), 191(15), 135(6)
445(100), 243(44), 183(6), 139(3)
C25H23O12
C20H29O11
−1.7
−2.5
7.2
22.4
dicaffeoylqunic acid
unidetified
187.5479.1169
609.1773
+
+
317(100)
301(100), 463(4)
C29H19O7
C35H29O10
−9.1
−2.9
14.9
41.0
isorhamnetin-hexoside
kaempferide-hexoside-deoxyhexoside
197.5477.1045
711.2156
-
-
477(100), 299(65), 271(63), 315(46)
711(100), 549(20), 433(10), 271(66)
C22H21O12
C32H39O18
−1.4
−2.0
10.3
9.1
isorhamnetin-hexoside
unidentified-hexoside deoxyhexoside-pentoside (flavonoid)
2010.3475.1216+271(100)C23H23O113.97.4apigenin-acylhexoside
2110.6519.1141-271(72), 299(46), 313(16), 151(7)C24H23O130.51.9isorhamnetin-acylhexoside
2216.7447.2009+219(100), 181(65), 231(30), 411(25), 358(23)C24H31O81.08.8unidentified
Table 6. Compounds identified in the cistus (Cistus L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 6. Compounds identified in the cistus (Cistus L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4305.0667-305(100), 219(12), 165(8)C15H13O7−0.15.1gallocatechin isomer
21.4469.0054-425(100), 299(24)C21H9O13−1.012.5valoneic acid dilacton isomer
31.8633.0743-301(100), 275(49), 229(23), 257(22)C27H21O18−1.51.1strictinin isomer
42.0305.0672
591.1370
-
-
305(100), 219(13), 261(8), 179(8)
285(100), 305(12)
C15H13O7
C27H27O15
−1.9
−2.5
5.4
41.7
gallocatechin isomer
unidentified
52.3289.0722
633.0742
-
-
289(100), 245(17), 203(9)
301(100), 275(41), 257(22), 229(11)
C15H13O6
C27H21O18
−1.6
−1.4
1.1
35.6
epicatechin
strictinin isomer
64.2479.0846-316(100), 271(83)C21H19O13−3.213.7myricetin-hexoside
74.7327.1458-327(100), 165(10)C16H23O7−2.89.2unidentified
85.0449.0738-316(100), 271(68)C20H17O12−2.84.1myricetin-pentoside
95.2463.0897-316(100), 271(91), 179(2)C21H19O12−3.23.5myricetin-deoxyhexoside
105.3463.0898-271(100), 300(83)C21H19O12−3.60.8quercetin-hexoside
115.4609.1474-271(100), 300(76)C27H29O16−2.16.5quercetin-hexoside-deoxyhexoside
126.1433.0785-300(100), 271(86), 255(35), 243(18)C20H17O11−2.05.8quercetin-pentoside
136.2449.1075+197(100), 287(34), 179(11)C21H21O110.911.9unidentified
146.5577.1573
447.0944
-
-
283(100), 255(57), 285(55), 431(24)
255(100), 227(87), 284(49)
C27H29O14
C21H19O11
−1.8
−2.6
15.6
11.4
kaempferol-di-deoxyhexoside
kaempferol-hexoside
156.7773.1905+147(100), 319(18)C36H37O192.444.2myricetin-di-deoxyhexoside-hexoside
167.1507.2219+219(100), 189(5)C26H35O101.19.2unidentified
177.8523.2199-475(100), 327(17), 149(7)C26H35O11−2.73.3unidentified
187.9627.1315+147(100), 319(58)C30H27O154.837.4myricetin-hexoside-deoxyhexoside
198.2551.2145-329(100), 269(36), 314(35)C27H35O12−1.97.2unidentified
209.8595.1432+147(100), 287(39)C30H27O132.513.1unidentified
Table 7. Compounds identified in the linden blossom (Tilia L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 7. Compounds identified in the linden blossom (Tilia L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4315.0715-315(100), 152(8)C13H15O92.00.3protocatechuoyl—hexoside
21.6153.0187-153(100), 109(40)C7H5O44.314.4protocatechuic acid
32.0577.1340-289(100), 407(72)C30H25O122.14.2procyanidin isomer
42.3289.0712-289(100)C15H13O61.82.3catechin
52.5353.0867
577.1341
-
-
191(100), 353(6)
289(100), 407(71)
C16H17O9
C30H25O12
3.1
1.8
23.4
7.4
chlorogenic acid
procyanidin isomer
62.9577.1344-289(100), 407(72)C30H25O121.213.7procyanidin isomer
73.3289.0714-289(100), 245(19), 203(9)C15H13O61.35.2catechin
84.8609.1457-299(100), 271(63), 447(12)C27H29O160.717.2quercetin-hexoside-deoxyhexoside
95.2593.1516-283(100), 285(43), 447(36)C27H29O15−0.723.8kaempferol-hexoside-deoxyhexoside
105.4609.1469-271(100), 300(68)C27H29O16−1.210.4quercetin-hexoside-deoxyhexoside
115.5465.1014
595.1634
+
+
303(100)
287(100)
C21H21O12
C27H31O15
2.8
3.9
4.9
7.6
quercetin-hexoside
kaempferol-hexoside-deoxyhexoside
125.7449.1066
595.1634
+
+
303(100)
303(100), 449(4)
C21H21O11
C27H31O15
2.7
2.8
3.8
2.4
quercetin-deoxyhexoside
quercetin-di-deoxyhexoside
136.4595.1640+287(100)C27H31O153.05.3kaempferol-hexoside-deoxyhexoside
146.6449.1062
579.1690
711.2102
+
+
+
287(100)
287(100), 433(4)
287(100), 433(4)
C21H21O11
C27H31O14
C32H39O18
3.6
3.2
4.1
4.9
6.0
11.5
kaempferol-hexoside
kaempferol-di-deoxyhexoside
kaempferol-di-deoxyhexoside-pentoside
156.7447.0937-271(100), 300(73)C21H19O11−0.93.1quercetin-deoxyhexoside
167.5463.0886-301(100)C21H19O12−0.815.0quercetin-hexoside
179.8595.1429+147(100), 287(34)C30H27O132.924.8kaempferol-hexoside-deoxyhexoside-coumaric acid
1810.3593.1854+285(100), 447(6)C28H33O141.89.2unidentified-hexoside-deoxyhexoside (flavonoid)
1913.0327.2174-327(100), 211(9)C18H31O51.01.5unidentified
2014.2329.2327-329(100), 211(17)C18H33O52.13.2unidentified
2114.6289.2375+235(100), 253(74), 217(64), 135(19), 161(14)C16H33O4−0.78.0unidentified
Table 8. Compounds identified in the ribwort plantain (Plantago lanceolata L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 8. Compounds identified in the ribwort plantain (Plantago lanceolata L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4373.1142-373(100), 211(92), 123(24)C16H21O10−0.48.3geniposidic acid
22.1461.1672-461(100), 315(3)C20H29O12−1.77.5decaffeoylacteoside
33.3451.2192-405(100), 179(8), 243(8), 167(7)C20H35O11−1.74.6caryoptoside isomer
43.9813.1363-285(100), 637(23), 351(18), 461(15),C33H33O240.67.9luteolin-tri-oxyhexide isomer
54.1637.1044-285(100), 351(89)C27H25O180.420.9luteolin-di-oxyhexide isomer
64.6639.1941-639(100), 621(42), 161(28), 135(9), 447(7)C29H35O16−1.615.8unidentified phenylethanoid
74.7639.1933-639(100), 621(59), 161(28), 133(16), 475(11)C29H35O16−0.411.7unidentified phenylethanoid
85.4637.1046-285(100), 461(44)C27H25O180.07.6luteolin-di-oxyhexoside isomer
95.7461.0721
989.1849
639.1935
-
-
-
285(100)
285(100), 461(12), 813(8)
639(100), 285(64), 161(41), 477(32), 461(21)
C21H17O12
C43H41O27
C29H35O16
1.1
−0.8
−0.7
6.8
43.6
8.1
luteolin-oxyhexoside isomer
unidentified luteolin derivative (flavonoid)
unidentified phenylethanoid
106.3545.2231
477.1400
755.2407
-
-
-
545(100), 337(14), 235(10), 193(8)
477(100), 161(22), 133(11), 315(9), 179(2)
755(100), 161(21), 179(10), 593(10), 135(8)
C25H37O13
C23H25O11
C34H43O19
1.5
0.4
−0.4
10.4
9.5
12.5
unidentified
calceolarioside A isomer
forsythoside isomer
116.5623.1980
639.1930
-
-
623(100), 161(26), 461(12)
639(100), 161(30), 477(13), 133(6)
C29H35O15
C29H35O16
0.2
0.2
5.6
16.6
verbascoside isomer
unidentified phenylethanoid
126.9445.0779
755.2401
-
-
269(100)
755(100), 161(24), 593(11), 133(8)
C21H17O11
C34H43O19
−0.6
0.4
24.9
19.4
apigenin-oxyhexoside
forsythoside isomer
137.1623.1987-623(100), 161(17), 461(7), 133(5)C29H35O15−0.97.0verbascoside isomer
147.5475.0877-274(100), 299(73)C22H19O121.07.5kaempferide-oxyhexoside
158.0637.2138-637(100), 461(59), 175(41)C30H37O150.015.9leucoseptoside A isomer
168.0621.1826 321(100), 323(21), 179(18), 487(14)C29H33O15−0.24.8unidentified
178.4629.2674-583(100), 421(21), 451(13), 289(9)C26H45O17−1.95.9unidentified
1810.5651.2304-651(100), 175(24), 160(12), 193(7), 475(5)C31H39O15−1.512.5unidentified
Table 9. Compounds identified in the marshmallow (Althaea L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
Table 9. Compounds identified in the marshmallow (Althaea L.) extract using UHPLC-QTOF-MS/MS. Compound numbers correspond to those indicated in Figure 2.
PeakRT [min]Molecular Ion
[M-H]
Ion ModeMS/MS FragmentsFormulaError
[ppm]
mSigmaTentative Identification
11.4326.1246-164(100), 236(26), 147(20)C15H20NO7−0.216.1phenylalanyl-hexoside
22.5417.1043-417(100), 152(8)C17H21O12−1.04.6gentisic acid-dipentoside
32.8179.0357
361.0966
-
-
179(100), 135(62)
361(100), 281(13), 171(7)
C9H7O4
C24H13N2O2
−4.1
4.7
41.7
55.9
caffeic acid
unidentified
43.5227.0568-227(100), 139(22), 165(9)C10H11O6−3.19.2unidentified
53.7623.0037- C17H19O23S1.032.2flavonoid disulfo-hexoside
65.0193.0479+193(100), 134(36), 178(36), 191(10)C10H9O48.39.7scopoletin isomer
75.2425.0562-425(100), 297(88), 315(86), 241(75), 327(73)C14H17O152.538.1unidentified
85.9636.9843- C17H16O24S−1.712.3flavonoid sulfo-glycoside
96.1733.0950- C28H29O21S−3.137.4flavonoid sulfo-glycoside
106.3541.0317-254(100), 285(33), 175(9)C21H17O15S−4.312.5theograndin I isomer
116.4433.1521-433(100), 403(86), 311(76), 299(58)C22H25O9−3.95.5unidentified
126.7527.0522
639.1223
-
-
285(100), 527(4), 213(4), 447(4)
301(100), 371(25), 299(24), 459(22)
C21H19O14S
C27H27O18
−4.1
−3.1
40.7
62.4
flavonoid sulfo-glycoside
unidentified-deoxyhexoside-hexoside (flavonoid)
137.2524.2881-524(100), 362(50)C27H42NO9−3.125.3unidentified
147.3 unidentified
157.6557.0266-301(100), 254(77), 315(58), 271(42)C21H17O16S−4.221.0theograndin II isomer
168.5555.0464 254(100), 284(30), 299(24), 175(7)C22H19O15S−2.59.6flavonoid sulfo-oxyhexoside
178.9541.0672-299(100), 284(68), 461(6)C22H21O14S−2.714.1flavonoid sulfo-hexoside
188.9541.0310-285(100), 254(67), 461(22)C21H17O15S−3.134.2flavonoid sulfo-oxyhexoside
199.1571.0411-300(100), 254(79), 315(46), 491(23)C22H19O16S−2.024.2flavonoid sulfo-oxyhexoside
209.4307.0731-233(100), 205(76), 263(75), 191(9)C17H11N2O4−2.22.1unidentified
2110.5475.0896- C22H19O12−3.156.1unidentified
2211.4555.0469-254(100), 284(80), 299(71), 475(35), 175(40)C22H19O15S−3.41.8flavonoid sulfo-oxyhexoside
2318.1311.2241- C18H31O4−4.24.5unidentified
2419.3459.2037- C25H31O8−2.824.7unidentified
2519.8459.2030- C25H31O8−1.356.6unidentified
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ziarno, M.; Kozłowska, M.; Ścibisz, I.; Kowalczyk, M.; Pawelec, S.; Stochmal, A.; Szleszyński, B. The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity. Appl. Sci. 2021, 11, 3898. https://doi.org/10.3390/app11093898

AMA Style

Ziarno M, Kozłowska M, Ścibisz I, Kowalczyk M, Pawelec S, Stochmal A, Szleszyński B. The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity. Applied Sciences. 2021; 11(9):3898. https://doi.org/10.3390/app11093898

Chicago/Turabian Style

Ziarno, Małgorzata, Mariola Kozłowska, Iwona Ścibisz, Mariusz Kowalczyk, Sylwia Pawelec, Anna Stochmal, and Bartłomiej Szleszyński. 2021. "The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity" Applied Sciences 11, no. 9: 3898. https://doi.org/10.3390/app11093898

APA Style

Ziarno, M., Kozłowska, M., Ścibisz, I., Kowalczyk, M., Pawelec, S., Stochmal, A., & Szleszyński, B. (2021). The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity. Applied Sciences, 11(9), 3898. https://doi.org/10.3390/app11093898

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop